{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T12:25:54Z","timestamp":1762431954152,"version":"build-2065373602"},"reference-count":45,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology - Research and Practice"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/j.prp.2021.153383","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T07:04:43Z","timestamp":1613545483000},"page":"153383","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["DNA mismatch repair deficiency and p53 abnormality are age-related events in mixed endometrial carcinoma with a clear cell component"],"prefix":"10.1016","volume":"220","author":[{"given":"Naoyuki","family":"Ida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiichiro","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masayuki","family":"Saijo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Atsuko","family":"Nasu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tadashi","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hisashi","family":"Masuyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9989-5144","authenticated-orcid":false,"given":"Hiroyuki","family":"Yanai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.prp.2021.153383_bib0005","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1177\/1933719110368433","article-title":"Minor serous and clear cell components adversely affect prognosis in\u2019 \u2019mixed-type\u2019\u2019 endometrial carcinomas: a clinicopathologic study of 36 stage-I cases","volume":"17","author":"Quddus","year":"2010","journal-title":"Reprod. Sci."},{"issue":"Suppl. 1","key":"10.1016\/j.prp.2021.153383_bib0010","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1097\/PGP.0000000000000512","article-title":"Issues in the differential diagnosis of uterine low-grade endometrioid carcinoma, including mixed endometrial carcinomas: recommendations from the international society of gynecological pathologists","volume":"38","author":"Rabban","year":"2019","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.prp.2021.153383_bib0015","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/jog.13863","article-title":"Annual report of the committee on gynecologic oncology, the Japan Society of Obstetrics and Gynecology: annual patients report for 2015 and annual treatment report for 2010","volume":"45","author":"Nagase","year":"2019","journal-title":"J. Obstet. Gynaecol. Res."},{"key":"10.1016\/j.prp.2021.153383_bib0020","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/ajcp\/aqz083","article-title":"The prognosis of stage IA mixed endometrial carcinoma","volume":"152","author":"Li","year":"2019","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.prp.2021.153383_bib0025","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1097\/PAS.0b013e3180339ed7","article-title":"Endometrioid neoplasms with clear cells: a report of 21 cases in which the alteration is not of typical secretory type","volume":"31","author":"Silva","year":"2007","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2021.153383_bib0030","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1177\/1066896917731862","article-title":"Endometrial serous carcinoma with clear-cell change: frequency and immunohistochemical analysis","volume":"26","author":"Hariri","year":"2018","journal-title":"Int. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2021.153383_bib0035","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/his.12581","article-title":"Targeted mutation analysis of endometrial clear cell carcinoma","volume":"66","author":"Hoang","year":"2015","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2021.153383_bib0040","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1038\/modpathol.2015.43","article-title":"Refining prognosis and identifying targetable pathways for high-risk endometrial cancer; a TransPORTEC initiative","volume":"28","author":"Stelloo","year":"2015","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2021.153383_bib0045","doi-asserted-by":"crossref","first-page":"3261","DOI":"10.1002\/cncr.30745","article-title":"Somatic mutation profiles of clear cell endometrial tumors revealed by whole exome and targeted gene sequencing","volume":"123","author":"Le Gallo","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.prp.2021.153383_bib0050","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1002\/path.4947","article-title":"The genetic landscape of endometrial clear cell carcinomas","volume":"243","author":"DeLair","year":"2017","journal-title":"J. Pathol."},{"key":"10.1016\/j.prp.2021.153383_bib0055","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/PAS.0000000000001209","article-title":"Targeted molecular and immunohistochemical analyses of endometrial clear cell carcinoma show that POLE mutations and DNA mismatch repair protein deficiencies are uncommon","volume":"43","author":"Baniak","year":"2019","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2021.153383_bib0060","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1097\/PAS.0b013e31825dd4b3","article-title":"The diagnosis of endometrial carcinomas with clear cells by gynecologic pathologists: an assessment of interobserver variability and associated morphologic features","volume":"36","author":"Fadare","year":"2012","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2021.153383_bib0065","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/PAS.0b013e31827f576a","article-title":"Poor interobserver reproducibility in the diagnosis of high-grade endometrial carcinoma","volume":"37","author":"Gilks","year":"2013","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2021.153383_bib0070","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1038\/modpathol.2013.102","article-title":"Reproducibility of histological cell type in high-grade endometrial carcinoma","volume":"26","author":"Han","year":"2013","journal-title":"Mod. Pathol."},{"issue":"Suppl. 1","key":"10.1016\/j.prp.2021.153383_bib0075","doi-asserted-by":"crossref","first-page":"S40","DOI":"10.1097\/PGP.0000000000000491","article-title":"High-grade endometrial carcinomas: morphologic and immunohistochemical features, diagnostic challenges and recommendations","volume":"38","author":"Murali","year":"2019","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.prp.2021.153383_bib0080","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1097\/01.pgp.0000092161.33490.a9","article-title":"Unusual epithelial and stromal changes in myoinvasive endometrioid adenocarcinoma: a study of their frequency, associated diagnostic problems, and prognostic significance","volume":"22","author":"Murray","year":"2003","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.prp.2021.153383_bib0085","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.humpath.2007.05.022","article-title":"Routinely assessed morphological features correlate with microsatellite instability status in endometrial cancer","volume":"39","author":"Shia","year":"2008","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2021.153383_bib0090","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1097\/PAS.0000000000001353","article-title":"Histologic appearance and immunohistochemistry of DNA mismatch repair protein and p53 in endometrial carcinosarcoma: impact on prognosis and insights into tumorigenesis","volume":"43","author":"Saijo","year":"2019","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2021.153383_bib0095","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1097\/00000478-199206000-00008","article-title":"Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic features","volume":"16","author":"Sherman","year":"1992","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2021.153383_bib0100","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/PGP.0000000000000162","article-title":"Endometrial carcinomas with clear cells: a study of a heterogeneous group of tumors including interobserver variability, mutation analysis, and immunohistochemistry with HNF-1\u03b2","volume":"34","author":"Han","year":"2015","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.prp.2021.153383_bib0105","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1097\/PGP.0000000000000369","article-title":"Frequent mismatch repair protein deficiency in mixed endometrioid and clear cell carcinoma of the endometrium","volume":"36","author":"Kobel","year":"2017","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.prp.2021.153383_bib0110","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0046-8177(98)80002-6","article-title":"Clear cell carcinoma of the endometrium is characterized by a distinctive profile of p53, Ki-67, estrogen, and progesterone receptor expression","volume":"29","author":"Lax","year":"1998","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2021.153383_bib0115","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1111\/his.12286","article-title":"Immunohistochemical characterization of prototypical endometrial clear cell carcinoma--diagnostic utility of HNF-1beta and oestrogen receptor","volume":"64","author":"Hoang","year":"2014","journal-title":"Histopathology"},{"key":"10.1016\/j.prp.2021.153383_bib0120","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.humpath.2019.06.005","article-title":"Clear cell carcinoma of the endometrium: an immunohistochemical and molecular analysis of 45 cases","volume":"92","author":"Zannoni","year":"2019","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2021.153383_bib0125","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/PAS.0000000000000536","article-title":"Molecular analysis of mixed endometrial carcinomas shows clonality in most cases","volume":"40","author":"Kobel","year":"2016","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2021.153383_bib0130","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/PGP.0000000000000111","article-title":"Should endometrial clear cell carcinoma be classified as Type II endometrial carcinoma?","volume":"34","author":"Bae","year":"2015","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.prp.2021.153383_bib0135","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1097\/PAS.0000000000001461","article-title":"Endometrial carcinomas with a \u201cSerous\u201d component in young women are enriched for DNA mismatch repair deficiency, lynch syndrome, and POLE exonuclease domain mutations","volume":"44","author":"Conlon","year":"2020","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2021.153383_bib0140","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1097\/01.AOG.0000239097.42987.0c","article-title":"Improved survival with an intact DNA mismatch repair system in endometrial cancer","volume":"108","author":"Cohn","year":"2006","journal-title":"Obstet. Gynecol."},{"key":"10.1016\/j.prp.2021.153383_bib0145","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1097\/01.pas.0000213423.30880.ac","article-title":"Microsatellite instability in endometrioid type endometrial adenocarcinoma is associated with poor prognostic indicators","volume":"31","author":"An","year":"2007","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2021.153383_bib0150","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.ygyno.2011.06.005","article-title":"Clinicopathologic significance of DNA mismatch repair protein defects and endometrial cancer in women 40years of age and younger","volume":"123","author":"Shih","year":"2011","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.prp.2021.153383_bib0155","doi-asserted-by":"crossref","first-page":"3062","DOI":"10.1200\/JCO.2016.67.8722","article-title":"Clinicopathologic significance of mismatch repair defects in endometrial cancer: an NRG oncology\/gynecologic oncology group study","volume":"34","author":"McMeekin","year":"2016","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.prp.2021.153383_bib0160","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1097\/PAS.0b013e318197a046","article-title":"Selection of endometrial carcinomas for DNA mismatch repair protein immunohistochemistry using patient age and tumor morphology enhances detection of mismatch repair abnormalities","volume":"33","author":"Garg","year":"2009","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2021.153383_bib0165","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jamaoncol.2015.2151","article-title":"Association of polymerase e-Mutated and microsatellite-instable endometrial cancers with neoantigen load, number of tumor-infiltrating lymphocytes, and expression of PD-1 and PD-L1","volume":"1","author":"Howitt","year":"2015","journal-title":"JAMA Oncol."},{"key":"10.1016\/j.prp.2021.153383_bib0170","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1097\/PAS.0000000000000436","article-title":"Immunohistochemical comparison of ovarian and uterine endometrioid carcinoma, endometrioid carcinoma with clear cell change, and clear cell carcinoma","volume":"39","author":"Lim","year":"2015","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2021.153383_bib0175","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0192881","article-title":"The ARID1A, p53 and ss-Catenin statuses are strong prognosticators in clear cell and endometrioid carcinoma of the ovary and the endometrium","volume":"13","author":"Heckl","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.prp.2021.153383_bib0180","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/modpathol.2013.144","article-title":"ARID1A loss correlates with mismatch repair deficiency and intact p53 expression in high-grade endometrial carcinomas","volume":"27","author":"Allo","year":"2014","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2021.153383_bib0185","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1038\/modpathol.2013.96","article-title":"Loss of ARID1A expression and its relationship with PI3K-Akt pathway alterations, TP53 and microsatellite instability in endometrial cancer","volume":"26","author":"Bosse","year":"2013","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2021.153383_bib0190","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.ygyno.2020.04.043","article-title":"Molecular subtypes of clear cell carcinoma of the endometrium: opportunities for prognostic and predictive stratification","volume":"158","author":"Kim","year":"2020","journal-title":"Gynecol. Oncol."},{"key":"10.1016\/j.prp.2021.153383_bib0195","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/modpathol.3800057","article-title":"Molecular characterization of uterine clear cell carcinoma","volume":"17","author":"An","year":"2004","journal-title":"Mod. Pathol."},{"key":"10.1016\/j.prp.2021.153383_bib0200","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1097\/IGC.0000000000001303","article-title":"Comparative use of napsin a and glypican 3 to distinguish endometrial clear cell from serous and endometrioid carcinomas","volume":"28","author":"Miller","year":"2018","journal-title":"Int. J. Gynecol. Cancer"},{"key":"10.1016\/j.prp.2021.153383_bib0205","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/PAS.0000000000000085","article-title":"Frequent expression of napsin A in clear cell carcinoma of the endometrium: potential diagnostic utility","volume":"38","author":"Fadare","year":"2014","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.prp.2021.153383_bib0210","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.humpath.2015.03.008","article-title":"Napsin A is frequently expressed in clear cell carcinoma of the ovary and endometrium","volume":"46","author":"Iwamoto","year":"2015","journal-title":"Hum. Pathol."},{"key":"10.1016\/j.prp.2021.153383_bib0215","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/PAI.0000000000000350","article-title":"Infrequent immunohistochemical expression of napsin a in endometrial carcinomas","volume":"25","author":"Al-Maghrabi","year":"2017","journal-title":"Appl. Immunohistochem. Mol. Morphol."},{"key":"10.1016\/j.prp.2021.153383_bib0220","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/PGP.0000000000000443","article-title":"Despite diagnostic morphology, many mixed endometrial carcinomas show unexpected immunohistochemical staining patterns","volume":"37","author":"Matrai","year":"2018","journal-title":"Int. J. Gynecol. Pathol."},{"key":"10.1016\/j.prp.2021.153383_bib0225","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/his.14015","article-title":"Incorporation of molecular characteristics into endometrial cancer management","volume":"76","author":"Vermij","year":"2020","journal-title":"Histopathology"}],"container-title":["Pathology - Research and Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033821000443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0344033821000443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,6]],"date-time":"2025-10-06T06:45:11Z","timestamp":1759733111000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0344033821000443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":45,"alternative-id":["S0344033821000443"],"URL":"https:\/\/doi.org\/10.1016\/j.prp.2021.153383","relation":{},"ISSN":["0344-0338"],"issn-type":[{"type":"print","value":"0344-0338"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DNA mismatch repair deficiency and p53 abnormality are age-related events in mixed endometrial carcinoma with a clear cell component","name":"articletitle","label":"Article Title"},{"value":"Pathology - Research and Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.prp.2021.153383","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier GmbH. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"153383"}}